Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 3 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Peritoneal Neoplasms 1 Osteosarcoma 1 Liver, Cancer of, Primary Resectable 1 Hepatocellular Carcinoma Resectable 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Advanced Gastric Cancer 1 Acute Toxic Effects 1

Interventions

Oxaliplatin 200 Capecitabine 116 S 1 (combination) 106 Fluorouracil 105 Docetaxel 100 Cisplatin 88 Leucovorin 75 Paclitaxel 71 Irinotecan 68 apatinib 43 sintilimab 42 Drug Therapy 42 Surgical Procedures, Operative 37 Hyperthermic Intraperitoneal Chemotherapy 34 pembrolizumab 32 Radiotherapy 31 Trastuzumab 30 Gastrectomy 23 Nivolumab 22 Epirubicin 22 Tegafur 21 Bevacizumab 21 XELOX 20 titanium silicide 19 camrelizumab 19 tislelizumab 17 Ramucirumab 17 Carboplatin 16 Neoadjuvant Therapy 15 Endoscopic Mucosal Resection 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Stomach Neoplasms × lobaplatin × Clear all

NCT04808466 2022-02-21

WUHIPEC01

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡